Table 1.

Clinical Outcomes after Intravitreal Injection of Bevacizumab

	Complete response	Partial response	No satisfactory response
Sex
Male (n = 19)	3 (15.8)	12 (63.1)	4 (21.1)
Female (n = 13)	4 (30.8)	6 (46.2)	3 (23.1)
Diabetes
IDDM (n = 7)	0 (0)	6 (85.7)	1 (14.3)
NIDDM (n = 25)	7 (28.0)	12 (48.0)	6 (24.0)
Age	63.9 ± 4.6	61.1 ± 4.1	67.7 ± 5.9

IDDM: Insulin-dependent diabetes mellitus; NIDDM: Non-insulin-dependent diabetes mellitus; SD: standard deviation

Data are presented as mean ± SD or No (%).